ESCI期刊Molecular and Clinical Oncology 2024/2025影響因子:1.402 (MOL CLIN ONCOL) (2049-9450). (ONCOLOGY)(腫瘤學(xué))Emerging Sources

密度

ESCI期刊Molecular and Clinical Oncology(20 21 REV HIST)影響因子


ESCI期刊Molecular and Clinical Oncology(MOL CLIN ONCOL)影響因子@(腫瘤學(xué))學(xué)科排名


ESCI期刊Molecular and Clinical Oncology(20 21 REV HIST)總引論文


ESCI期刊Molecular and Clinical Oncology(MOL CLIN ONCOL)總引論文@(腫瘤學(xué))學(xué)科排名


ESCI期刊Molecular and Clinical Oncology(20 21 REV HIST)影響因子


ESCI期刊Molecular and Clinical Oncology(MOL CLIN ONCOL)總引頻次@(腫瘤學(xué))學(xué)科排名


ESCI期刊Molecular and Clinical Oncology(20 21 REV HIST)即時影響因子


ESCI期刊Molecular and Clinical Oncology(MOL CLIN ONCOL)即時影響因子@(腫瘤學(xué))學(xué)科排名


ESCI期刊Molecular and Clinical Oncology(20 21 REV HIST)五年累積影響因子


ESCI期刊Molecular and Clinical Oncology(MOL CLIN ONCOL)五年累積影響因子@(腫瘤學(xué))學(xué)科排名

MORPH

Antagonist

Submitted on: 20 March 2023. Revised on: 30 March 2023. Accepted on: 08 April 2023. Molecular and Clinical Oncology

貧困

Submitted on: 11 June 2016. Revised on: 26 June 2016. Accepted on: 08 July 2016. Molecular and Clinical Oncology

wall-stress

Submitted on: 07 August 2001. Revised on: 27 August 2001. Accepted on: 08 September 2001. Molecular and Clinical Oncology

Cleave

鎮(zhèn)痛劑

Submitted on: 17 May 2018. Revised on: 14 June 2018. Accepted on: 26 June 2018. Molecular and Clinical Oncology

Keshan-disease

Submitted on: 16 March 2010. Revised on: 28 March 2010. Accepted on: 04 April 2010. Molecular and Clinical Oncology

是突襲

Submitted on: 11 December 2007. Revised on: 09 January 2008. Accepted on: 16 January 2008. Molecular and Clinical Oncology

被詛咒的人

Submitted on: 06 September 2022. Revised on: 25 September 2022. Accepted on: 14 October 2022. Molecular and Clinical Oncology